PuraPharm Corporation Limited reported unaudited consolidated earnings results for the year ended December 31, 2015. For the year, the company reported revenue of HKD 473,900,000 against HKD 366,352,000 a year ago. Profit before tax was HKD 40,134,000 against HKD 42,330,000 a year ago.

Profit for the period was HKD 28,458,000 against HKD 34,507,000 a year ago. Profit for the period attributable to owners of the parent was HKD 28,458,000 against HKD 34,463,000 a year ago. Basic and diluted earnings per share attributable to the ordinary equity holders of the company was HKD 0.15 against HKD 74.54 a year ago.

Adjusted profit, which consists of profit for the year adjusted for listing expense, was HKD 47.5 million for the year ended December 2015, increased by HKD 7.2 million or 17.9% compared to HKD 40.3 million in last year. The increase was mainly attributable to the increase in revenue and gross profit improvement. Net cash used in operating activities was HKD 12,570,000 against net cash form operating activities of HKD 31,091,000 for the same period a year ago.